The Oncology Institute Shares Key Financial Updates and Insights
The Oncology Institute Earnings Announcement
The Oncology Institute, Inc. (NASDAQ: TOI) is paving the way in value-based community oncology care. Recently, the organization revealed essential details about its third quarter financial performance for 2025. This public announcement marks an important milestone for the company and its stakeholders.
Upcoming Earnings Release
On November 13, 2025, after the market closes, The Oncology Institute will disclose its financial results for the third quarter of the fiscal year. Investors and the general public will have the opportunity to gain insights into the company’s performance and strategic direction.
Conference Call Details
The anticipated conference call will occur on the same day at 5:00 p.m. Eastern Time. Attendees can join the call by dialing 1-877-407-0789, while international participants may use 1-201-689-8562. Following the live call, a recording will be accessible for two hours at 1-844-512-2921 or 1-412-317-6671 for international listeners. The passcode required is 13756737, with replays available until November 20, 2025.
Engagement Opportunities
For those interested in a more detailed analysis, The Oncology Institute encourages participation through a live webcast. This webcast will allow stakeholders to follow along as insights unfold, accessible on the company’s Investor Relations website.
Understanding The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) specializes in delivering personalized cancer care. It treats approximately 1.9 million patients through a combination of clinical trials, transfusions, and other innovative care delivery models typically associated with leading healthcare providers. Currently, with over 180 employed and affiliate clinicians, TOI operates more than 100 clinics across five states, emphasizing a commitment to improving cancer care quality and accessibility.
Company Contacts
Communication with The Oncology Institute is encouraged for media and investor inquiries. Interested media representatives can reach out at marketing@theoncologyinstitute.com.
Investors can connect with The Oncology Institute for further information at TOI@icrhealthcare.com.
Frequently Asked Questions
What is the date of the upcoming earnings release?
The earnings release for the third quarter of 2025 will occur on November 13, 2025.
How can investors participate in the conference call?
Investors can participate by calling 1-877-407-0789 or 1-201-689-8562 for international calls.
What does The Oncology Institute focus on?
The Oncology Institute specializes in community-based oncology care, focusing on value-based treatment and advanced clinical practices.
Who can I contact for media inquiries?
Media inquiries can be directed to marketing@theoncologyinstitute.com.
Where can I find more information about The Oncology Institute?
Detailed information can be found on The Oncology Institute's Investor Relations website.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.